Home / Stock ratings / ALAB
Stock rating · Semiconductors & Related Devices
Astera Labs, Inc. (ALAB) Stock Rating & Analysis
As of October 7, 2026, MELANY rates Astera Labs, Inc. 67 out of 100 (Favorable). Its highest factor score is earnings track record at 91, and its lowest is valuation at 17.
MELANY ratingRated 2026-10-07ALAB · composite score
About Astera Labs, Inc.
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform combines semiconductor technology, microcontrollers, sensors, and software to improve performance, scalability, and data management. The company offers integrated circuits (ICs), boards, and modules for hyperscalers and system OEMs, with solutions focused on data, network, and memory management in AI-driven platforms.
Rating as of 2026-10-07 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
How ALAB's rating has moved
- -1Past week, since Sep 30: score fell 1 point to 67.
- +8Past four weeks, since Sep 9: Very Promising to Favorable, score rose 8 points to 67.
Weekly points: Sep 9: 59 · Sep 16: 61 · Sep 23: 64 · Sep 30: 68 · Oct 7: 67 (this page).
From MELANY's own dated rating record. A tier change is reported as a move between named tiers; the score carries the direction.
Why ALAB scores 67/100
ALAB's 8 factor scores run from 17 to 91, and 4 of them sit above its composite of 67. Here is how ALAB breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 61.0x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
- Gross margin 75%
- ROE 26%
Direction and relative strength of the recent share-price trend.
- Price +24.8% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +15%
- Earnings in 28 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Institutional net buying +3.7%
Near-term events that could move the stock.
- Earnings in 28 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How ALAB compares
As of October 7, 2026, Astera Labs, Inc. is tied for 9th of the 21 companies with a MELANY rating page in its SEC industry group (Semiconductors & Related Devices), where the average score is 67.
Key risks for ALAB
- Trailing P/E 192x, priced for sustained growth, any miss could de-rate hard
- High beta 3.7, amplifies market drawdowns 1.8x+ in selloffs
- Performance partly driven by AI infrastructure (semis), rotation away from this theme would hurt
Sector and theme context
Astera Labs, Inc. sits in the AI infrastructure (semis) theme, which MELANY currently rates 95/100 for strength. Theme strength feeds ALAB's momentum and catalyst factors above.
ALAB trade plan (Pro)
MELANY has a full position plan for Astera Labs, Inc.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates ALAB
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Astera Labs, Inc.'s 67/100 reflects speculative factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about ALAB
Is Astera Labs, Inc. (ALAB) a buy?
As of 2026-10-07, MELANY rated Astera Labs, Inc. Favorable with a composite score of 67/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Astera Labs, Inc.'s MELANY score?
Astera Labs, Inc. (ALAB) has a MELANY composite score of 67/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the ALAB stock rating calculated?
MELANY scores ALAB from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Astera Labs, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Astera Labs, Inc. (ALAB) Favorable with a composite of 67/100 as of 2026-10-07. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the ALAB stock price forecast?
MELANY does not publish price targets or forecasts for ALAB. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 67/100 across eight factors for Astera Labs, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is ALAB stock overvalued or undervalued?
MELANY's valuation factor currently reads 17/100 for Astera Labs, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives ALAB's read.
What price should I buy ALAB at?
Rather than chasing the current price, MELANY computes a smart entry zone for ALAB: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying ALAB stock?
The top risks MELANY currently flags for Astera Labs, Inc.: Trailing P/E 192x, priced for sustained growth, any miss could de-rate hard; High beta 3.7, amplifies market drawdowns 1.8x+ in selloffs; Performance partly driven by AI infrastructure (semis), rotation away from this theme would hurt. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Astera Labs, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 83/100 for Astera Labs, Inc., and earnings track record, at 91/100. The 67/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will ALAB stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 84/100 for ALAB right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this ALAB rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-07. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores ALAB continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, ALAB included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.